Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of IL-38 protein in preparation of medicine for treating ophthalmic diseases

An ophthalmic disease and protein technology, applied in the field of biomedicine, can solve the problems of blank and insufficient ophthalmic drugs, and achieve the effect of easy drug administration, easy and fast onset treatment plan, and low cost

Pending Publication Date: 2020-09-22
REYOUNG SUZHOU BIOLOGY SCI & TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The purpose of the present invention is to provide a new application of IL-38 protein in the preparation of medicines for the treatment of ophthalmic diseases in view of the current situation and existing deficiencies of the prior art, which solves the blank of medicines for the treatment of symptoms and signs of dry eye disease in China, and Serious shortage of ophthalmic drugs to treat neovascularization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of IL-38 protein in preparation of medicine for treating ophthalmic diseases
  • Application of IL-38 protein in preparation of medicine for treating ophthalmic diseases
  • Application of IL-38 protein in preparation of medicine for treating ophthalmic diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Preparation of IL-38 protein in different forms of embodiment 1

[0045] This example typically exemplifies the preparation of rhIL-38 protein and its fusion form of human serum albumin, and also exemplifies the method of expressing the target protein and the purification method of the Escherichia coli prokaryotic expression system and the Pichia pastoris expression system. The same or similar methods and steps can be used for other rhIL-38 protein fusion proteins, such as the form of rhIL-38 protein fusion IgG Fc fragment (rhIL-38-IgG Fc fusion protein), the form of fusion single domain antibody, human transferrin protein (transferrin) or other components that can extend the half-life-rhIL-38 protein fusion protein for preparation. The same or similar methods and steps can be used to express the target protein in other expression systems, such as mammalian cell expression system, insect expression system, etc.

[0046] (1) Preparation of rhIL-38 protein

[0047] The ...

Embodiment 2

[0055] Example 2: ELISA method to detect the binding of different forms of IL-38 protein to IL-36R

[0056] In this example, the binding ability of rhIL-38 protein, HSA-rhIL-38 fusion protein and rhIL-38-IgG Fc fusion protein to IL-36R protein was detected, and the EC50 was detected.

[0057] Experimental procedure

[0058] 1) Add 100 μL of carbonate coating solution containing 0.5 μg / mL IL-36R protein to the microwell plate, and coat overnight at 4°C;

[0059] 2) Tap off the liquid in the wells, add 300 μL of washing solution (0.1% PBST) to each well to wash the plate 3 times, soak the plate for 2 minutes each time and shake the plate gently to shake off the liquid in the plate, pat it on absorbent paper 3 times, and finally After one wash, pat dry on absorbent paper;

[0060] 3) Add 300 μL of blocking solution (PBS containing 1% BSA) to each well to seal the plate. Seal the plate with film and seal at 37°C for 1 hour;

[0061] 4) Repeat step 2);

[0062] 5) Add the stan...

Embodiment 3

[0074] Embodiment 3: ELISA method detects the combination of different forms of IL-38 protein and IL-1RI

[0075] In this example, the rhIL-38 protein, HSA-rhIL-38 fusion protein and rhIL-38-IgG Fc fusion protein were combined with IL-1RI protein, and their EC50 was detected.

[0076] Experimental procedure

[0077] 1) Add 100 μL of carbonate coating solution containing 10 μg / mL IL-1RI protein to the microwell plate, and coat overnight at 4°C;

[0078] 2) Tap off the liquid in the wells, add 300 μL of washing solution (0.1% PBST) to each well to wash the plate 3 times, soak the plate for 2 minutes each time and shake the plate gently to shake off the liquid in the plate, pat it on absorbent paper 3 times, and finally After one wash, pat dry on absorbent paper;

[0079] 3) Add 300 μL of blocking solution (PBS containing 1% BSA) to each well to seal the plate. Seal the plate with film and seal at 37°C for 1 hour;

[0080] 4) Repeat step 2).

[0081] 5) Add the standard curv...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of biological medicines, particularly relates to new application of IL-38 protein in preparation of a medicine for treating ophthalmic diseases, and more particularly relates to application in treatment of xerophthalmia, neovascularization and / or other ophthalmic diseases related to inflammation. The invention discloses a treatment effect of a medicine taking IL-38 protein and / or IL-38 protein fusion IgG Fc fragment form, fusion human serum albumin form and the like as active ingredients on the ophthalmic diseases. Results of in-vitro and in-vivo experimentsshow that when the medicine taking the IL-38 protein as the active ingredient is used for treating the ophthalmic diseases, the treatment effect is good, the treatment is simple and convenient, and anew choice is provided for treatment of the ophthalmic diseases.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to the application of IL-38 protein in the preparation of medicines for treating ophthalmic diseases. Background technique [0002] Interleukin (IL)-38 (also known as IL-1F10 and IL-1HY2) is the tenth member of the IL-1 superfamily discovered in 2001, and is one of the anti-inflammatory factors in the IL-1 superfamily. Its gene is located on chromosome 2 2q13-14.1, adjacent to genes encoding IL-1 receptor antagonist (IL-1Ra) and IL-36 receptor antagonist (IL-36Ra), and contains 5 exons, spanning 7.8kb of genomic DNA. Human IL-38 protein is composed of 152 amino acid residues, with a molecular weight of about 17-18KDa, and lacks signal peptide, N and O glycosylation sites and caspase-1 cleavage sites, and is the same as IL-1Ra and IL-36Ra. The origin is about 41% and 43%. [0003] IL-38 protein is expressed in epithelial cells in the skin, proliferating B cells and apoptotic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/20A61P27/02A61P9/10
CPCA61K38/20A61P27/02A61P9/10
Inventor 闫加庆郜鹏刘永李马琳郭树华
Owner REYOUNG SUZHOU BIOLOGY SCI & TECH CO LTD